The Effects of Dexmedetomidine on Postoperative Cognitive Function in Open Heart Surgery
- Conditions
- Open Heart SugeryNeuronal Damage
- Interventions
- Registration Number
- NCT06655025
- Lead Sponsor
- Sohag University
- Brief Summary
To assess the impact of Dexmedetomidine on postoperative cognitive function and serum Neuron Specific Enolase levels as an indicator of neuronal injury in patients undergoing open heart surgery
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- All
- Target Recruitment
- 32
- Patients of both sexes undergoing elective open-heart surgery
- Patients with a history of neurological disorders, severe renal or liver dysfunction, or contraindications to Dexmedetomidine as in patients with known QT prolongation, a history of other arrhythmias, symptomatic bradycardia, hypokalemia, or hypomagnesemia, and in patients receiving other drugs known to prolong the QT interval.
Patients with cognitive impairment, mental and psychological illness and chronic alcoholics, drug addicts, abuse of psychotropic substances, illiterate education
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Group B (Dexmedetomidine) Dexmedetomidine Dexmedetomidine infusion Group A (control) Dexmedetomidine normal saline infusion
- Primary Outcome Measures
Name Time Method postoperative cognitive function pre- oprerative , Mini-mental state examination (MMSE) will be performed at 1, 3 and 7 days after operation. using the Mini-Mental State Examination (MMSE) to evaluate cognitive status
- Secondary Outcome Measures
Name Time Method serum Neuron Specific Enolase levels pre-operative ,post-operative 12 hours serum Neuron Specific Enolase levels as an indicator of neuronal injury in patients undergoing open heart surgeries.
Trial Locations
- Locations (1)
Sohag University
🇪🇬Sohag, Egypt